Tailoring Treatment for Patients With HR+/HER2- METASTATIC BREAST CANCER: Examining the Role of Current and Emerging Endocrine Therapies

Meeting Date: 
Monday, May 12, 2025

Time:
12:00-1:00 PM ET

Location:
New York Presbyterian-Brooklyn Methodist Hospital
Brooklyn, NY

Faculty Speaker:
Ruta Rao, MD

Pin It on Pinterest

Scroll to Top

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers